lefebvre pierre j (29 Ergebnisse)

Zustand: Muy bueno. : Este libro, titulado 'New Aspects in Diabetes: Treatment Strategies with Alpha-Glucosidase Inhibitors. Third International Symposium on Acarbose', es una publicación de De Gruyter que aborda las estrategias de tratamiento para la diabetes, centrándose en los inhibidores de la alfa-glucosidasa. Recopila las actas del Tercer Simposio Internacional sobre Acarbosa, ofreciendo una visión profunda de los últimos avances y perspectivas en el manejo de esta enfermedad. Es una obra esencial para profesionales y académicos del campo de la medicina y la endocrinología. EAN: 9783110134698 Tipo: Libros Categoría: Salud y Bienestar|Ciencias Título: New Aspects in Diabetes Autor: Pierre J. Lefèbvre| Eberhard Standl Editorial: De Gruyter Idioma: en Páginas: 308 Formato: tapa dura.

cloth with Slipcase. Zustand: Wie neu. XX, 349 S. : Ill. Like new. Shrink wrapped. Sprache: Englisch Gewicht in Gramm: 905.

Broschiert. Zustand: Gut. 354 Seiten Das Buch befindet sich in einem ordentlich erhaltenen Zustand; Sprache: Englisch Gewicht in Gramm: 700.

gebundene Ausgabe. Zustand: Gut. 336 S. Das hier angebotene Buch stammt aus einer teilaufgelösten wissenschaftlichen Bibliothek und trägt die entsprechenden Kennzeichnungen (Rückenschild, Instituts-Stempel.). Schnitt und Einband sind etwas staubschmutzig; Einbandkanten sind leicht bestossen; Buchschnitt und Seitenränder alters-/papierbedingt leicht angebräunt; der Buchzustand ist ansonsten ordentlich und dem Alter entsprechend gut. Sprache: Englisch Gewicht in Gramm: 780.

Zustand: Good. *Price HAS BEEN REDUCED by 10% until Monday, July 13 (SALE Item)* 349 pp., Hardcover, ex library, else text and binding clean and tight. - If you are reading this, this item is actually (physically) in our stock and ready for shipment once ordered. We are not bookjackers. Buyer is responsible for any additional duties, taxes, or fees required by recipient's country.

Zustand: Very Good. *Price HAS BEEN REDUCED by 10% until Monday, July 13 (SALE Item)* 369 pp., paperback, light soiling to page edges else text clean & binding tight. - If you are reading this, this item is actually (physically) in our stock and ready for shipment once ordered. We are not bookjackers. Buyer is responsible for any additional duties, taxes, or fees required by recipient's country.

Zustand: New. In.

Zustand: New. In.

Zustand: New. In.

Zustand: New. In.

Zustand: New.

Zustand: New.

Zustand: New. pp. xii + 294.

Hardcover. Zustand: Brand New. 308 pages. 9.75x7.00x1.00 inches. In Stock.

Taschenbuch. Zustand: Neu. The Pathology of the Endocrine Pancreas in Diabetes | Pierre J. Lefebvre (u. a.) | Taschenbuch | xi | Englisch | 2011 | Springer | EAN 9783642726934 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.

Paperback. Zustand: Brand New. reprint edition. 369 pages. 9.10x6.10x0.90 inches. In Stock.

Paperback. Zustand: Brand New. reprint edition. 347 pages. 9.60x6.70x0.80 inches. In Stock.

Paperback. Zustand: Brand New. 1st edition. 380 pages. 9.61x6.69x0.87 inches. In Stock.

Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - Diabetes mellitus represents one of the most frequent and serious clinical syn dromes in contemporary medicine. Since the end of the nineteenth century, the endocrine pancreas has been implicated in the pathogenesis of this disease. Several pathologists of the twentieth century detected various lesions and mor phologic alterations in the pancreatic islets of diabetic patients, but the patho physiologic basis of their findings remained long obscure. The systematic mi croscopic work of WILLY GEPTS clarified the views and related the variety in histopathology to differences in origin, duration and clinical expression of the disease. Over the past two decades, the concept of a multifactorial origin of diabetes has become widely accepted. Various agents and mechanisms have been identified which can lead to a quantitative or qualitative deficit in pancre atic B-cells. The purpose of this book is to bring an update on the many path ways which may induce an absolute or relative insufficiency in insulin release and hence a diabetic state. Rather than bringing a complete account on all re search relevant to the understanding of the pathology of the diabetic pancreas, the authors of the various chapters of this volume have focussed on selected processes which can impair B-cell function, survival or regeneration.

Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - His scientific contributions are regarded as classics: the studies about the insulin effect on adipose tissue (together with George F. Cahill Jr. ), his work on the biosyn thesis and secretion of insulin (together with Lelio Orci and Claes W ollheim) and his studies on various spontaneous and induced diabetes syndromes in rodents (together with Bernard Jeanrenaud and Eleazar Shafrir). Albert Renold will be remembered for a long time by all who knew him for his achievements, for his kindness and his humanity. We dedicate the Proceedings of this symposium to his memory. Werner Creutzfeldt Pierre Lefebvre G6ttingen Liege History and Philosophy of Bayer Pharmaceutical Research W. -D. Busse Fachbereich Forschung Pharma, Bayer AG, D-5600 Wuppertal, FRG Research has a long tradition at Bayer. This year, 1988, marks 100 years of our pharmaceutical activities. In 1888 the first Bayer drug - phenacetin, an antipyreti- was synthesized, starting from a by-product of dye manufacture. This finding led to the establishment of a Pharmaceutical Department within Friedrich Bayer and Co. in Elberfeld, with all its associated facilities (Fig. 1). The beginning of the company itself, however, dates back to 1863. In that year, Friedrich Bayer started the produc tion of aniline dyestuffs in his private house in Barmen-Rittershausen. During the 125 years of the company's life and the 100 years of pharmaceuticals, many developments and products have been discovered by Bayer researchers and launched by Bayer.

Buch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - Frontmatter -- List of first-mentioned contributors -- Contents -- Introduction / Meyer, H. -- I. New aspects in diabetes mellitus -- The epidemiology of diabetes mellitus and its relationship with cardiovascular disease / Zimmet, P. / Serjeantson, S. -- Syndrome X: fact or fiction / Lebovitz, H. E. -- Strategies for the treatment of hyperglycemia in Syndrome X / Josse, R. G. -- Treatment strategies of Syndrome X - hypertension and vascular complications / Litbell, H. -- Lipid metabolism: metabolic consequences of moderate hypertriglyceridemia / Vega, G. L. -- Update on the treatment of NIDDM / Lefèbvre, P. J. / Sebeen, A. J. -- Hyperinsulinemia and macrovascular complications in NIDDM / Standi, E. / Janka, H. U. / Stiegler, H. / Mehnert, H. -- II. Quality of life in diabetes mellitus -- Diabetes and quality of life: some current issues in definition and research / Croog, S. H. -- Quality of life in patients with type II diabetes mellitus / Waadt, S. / Duran, G. / Waadt, M. / Herschbach, P. / Strian, F. -- Well-being in non-insulin-dependent diabetic patients (NIDDM) - a long-term follow-up / Toeller, M. -- III. Studies with acarbose -- Acarbose monotherapy in non-insulin-dependent diabetes mellitus - the German experience / Hanefeld, M. -- Acarbose in non-insulin-dependent diabetes mellitus: combination with sulfonylureas and interaction with diet / Willms, B. -- Clinical efficacy of BAY g 5421 (acarbose) in noninsulin- dependent diabetes mellitus (NIDDM) - a placebo-controlled double-blind comparative study / Goto, Yuichiro / Goto, Yosbio / Nakagawa, S. / Orimo, H. / Ikeda, Y. / Sakamoto, N. / Fukui, I. / Tarui, S. / Baba, S. / Kaneko, T. / Mimura, G. -- Effects of long-term administration of acarbose in patients with NIDDM - a double-blind study with placebo / Sakamoto, N. / Hotta, N. / Koh, N. / Sakakibara, F. / Haga, T. / Kobayashi, M. / Kakuta, H. / Sano, T. / Yamada, H. / Matsumae, H. / Kitazawa, S. -- Effects of acarbose on blood glucose control in insulindependent diabetes mellitus / Ikeda, Y. / Tsuruoka, A. / Izumi, K. / Yoshida, M. / Nakata, Y. / Omori, Y. / Sanaka, M. / Kitagawa, T. / Miyamoto, Y. / Fujita, H. / Kondo, M. / Sato, T. / Takeda, A. / Tanae, A. / Matsuoka, K. / Murakami, K. / Yamamoto, S. -- European experience in the treatment of IDDM with acarbose in combination with insulin / Raptis, S. A. -- Round table discussion on open questions and future aspects -- IV. Abstracts -- A multi-center, double-blind, placebo-controlled study of the long-term efficacy and safety of acarbose (BAYg 5421) in the treatment of obese patients with NIDDM treated by diet alone / Coniff, R. F. -- A multi-center, double-blind, placebo-controlled study of long-term efficacy and safety of acarbose (BAY g 5421) and sulfonylureas in the treatment of NIDDM inadequately controlled by maximal doses of sulfonylureas (SFU) / Coniff, R. F. / Innerfield, R. J. -- A multi-center, double-blind, comparative study of the long-term efficacy and safety of acarbose (BAY g 5421) vs. placebo in the treatment of patients with insulin requiring type II diabetes mellitus / Pi-Sunyer, F. X. -- Prospective, multi-center studies of the efficacy and safety of acarbose (BAY g 5421) in the treatment of type I diabetes mellitus / Schade, D. S. -- Two multi-center, double-blind, placebo-controlled studies of efficacy and safety of acarbose treatment of type I diabetes / Holander, P. / Coniff, R. F. -- Clinical study of reduced postprandial hyperglycemia by acarbose and glycemic impact of fructose and sucrose in insulin therapy / Wernecke, J. / Dreyer, M. / Fisch, R. / Michels, G. / Lührs, M. / Dammann, H. G. -- 6 months monotherapy of NIDDM with acarbose or glibenclamide / Spengler, M. / Hänsel, G. / Boehme, K. -- Decreased insulin requirement and postprandial insulin plasma concentrations under treatment with the a-glucosidase inhibitor acarbose / Hobler, H. / Spengler, M. -- Long-term treatment of BAY g 5421 (acarbose) in noninsulin- dependent diabetes mellitus / Goto, Yoshio / Toyota, T. / Oikawa, S. / Maruhama, Y. / Tamura, M. / Komatsu, K. / Fujiya, H. / Abe, R. / Kikuchi, H. -- Clinical efficacy and tolerability of acarbose in IDDM treatment / de la Calle, H. / Escobar, F. / Figuerola, D. / Gil, E. / Herrera-Pombo, J. L. / Jiménez, A. / de Leiva, A. / Pallardo, L. F. / Piñón, F. / Soler, J. / Tebar, J. / Vázquez, V. A. -- Effects of acarbose on the glycemic index of different foods / Calle, A. / Rodriguez, C. / Gil, E. -- Effects of acarbose on the release of gastrointestinal, pancreatic and hypophysial hormones including somatostatin in type II diabetics / Rohr, G. / Schmidt, I. / Schwedes, U. / Usadel, K. H. / Norenberg, Chr. / Spengler, M. -- Influence of acarbose on the release of gastrointestinal, pancreatic and hypophysial hormones including somatostatin in healthy volunteers / Rosak, C. / Boehm, B. O. / Althoff, P. H. / Hobler, H. / Boehme, K. -- Acarbose: an intestinal tract a-glucosidase inhibitor - pharmacological effects on insulin and glycemia in response to a sucrose load / Tawara, K. / Mochizuki, N. / Donkai, A. / Hikima, Y. -- Assessment of efficacy and tolerability of acarbose (Glucobay®) by clinical data pool / Spengler, M. / Cagatay, M. -- Long-term tolerability of acarbose / Spengler, M. / Hobler, H. / Cagatay, M. -- Assessment of efficacy and tolerability of acarbose in diabetic patients 5 - 16 years of age / Spengler, M. / Cagatay, M. -- Effect of acarbose repeated dosing on antipyrine test in healthy volunteers / Pinquier, J. L. / Pello, J. Y. / Key, E. / De Lauture, D. / D'Athis, P. / Strauch, G. / Olive, G. / Mover, I. / Prunieras, F. -- Discussion.

Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - Glucagon III complements Glucagon I and II published in 1983 in this series as Vols. 66/I and II. These three volumes truly represent a 'glucagon encyclopedia' and as such have no competitors in the scientific literature worldwide. In this volume, the most recent data on glucagon molecular biology are reviewed together with clinically relevant information on the role of glucagon in the pathophysiology of diabetes, the place of glucagon in medical imaging or in emergency medicine. Chapters are devoted to newly identified members of the glucagon family such as glucagon-like peptide-1 (GLP-1) and oxyntomodulin. Glucagon III is a comprehensive review of all information published on this important hormone since 1983 and is the reference book on the subject.

Zustand: New. 1992. Hardcover. . . . . . Books ship from the US and Ireland.

Softcover. Zustand: gut. Diabetes Mellitus: Pathophysiology and Therapy - Bayer AG Centenary Symposium Edinburgh, U.K., May 25-28, 1988 In deutscher Sprache. pages.

Zustand: gut. The Pathology of the Endocrine Pancreas in Diabetes In deutscher Sprache. pages.

Paperback. Zustand: Brand New. reprint edition. 566 pages. 9.50x6.60x1.60 inches. In Stock.

488 (4) pages, bien illustrées. - Toile vert illustré de l'éditeur; 8vo.(ca. 20 x 19 x 4 cm; ca. 1,1 kg.). *** Édition originale; Ouvrage de la 'Série Luxe', réservé aux adhérents des AMIS DU CLUB DU LIVRE DU MOIS. - Exemplaire numéroté; bel exemplaire.

1950. Paris Éditions de Minuit 1950 - Broché 13 cm x 21 5 cm 109 pages - Direction Marcel Bisiaux; textes et poèmes de Armen Lubin Jean Paulhan André Dhôtel Marcel Bisiaux Robert Musil Marcel Jouhandeau Alexei Remizov Maurice Lefebvre Georg Trakl John Audrey R. Sipran Mark Rutherford Alfred Kern Monique Chuffart Georges Lambrichts Dostoievski Jacques Brenner Arthur Adamov Dominique Arban Jeanine Arland Audiberti J.-J. Duval Philippe Jaccottet Pierre Klossowski M. Lecomte Pierre Leyris J.-M. Poursin Armand Robin René de Solier A. Tavera Henri Thomas- Bon état. Bon état.

Handbook of Experimental Pharmacology, 67/1. - Berlin, Springer Verlag 1983, 8°, XXVIII, 535 pp., 136 Fig.; XXX, 700 pp., 161 Fig., orig. Leinenband; ExBibExpl.